İ. BUGAN Et Al. , "Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.," PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, pp.1-11, 2019
BUGAN, İ. Et Al. 2019. Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.. PROSTATE CANCER AND PROSTATIC DISEASES , vol.22 , 1-11.
BUGAN, İ., Küçük, S., Karagöz, Z., FRASER, S., Kaya , H., Dodson, A., ... Foster, C.(2019). Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.. PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, 1-11.
BUGAN, İlknur Et Al. "Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.," PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, 1-11, 2019
BUGAN, İlknur Et Al. "Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.." PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, pp.1-11, 2019
BUGAN, İ. Et Al. (2019) . "Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.." PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, pp.1-11.
@article{article, author={İlknur BUGAN Et Al. }, title={Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.}, journal={PROSTATE CANCER AND PROSTATIC DISEASES}, year=2019, pages={1-11} }